The ABCB4 p.T175A variant as potential modulator of hepatic fibrosis in patients with chronic liver diseases: Looking beyond the cholestatic realm
Hepatology
.
2017 Aug;66(2):666-667.
doi: 10.1002/hep.29100.
Epub 2017 Jul 4.
Authors
Marcin Krawczyk
1
2
,
Monika Rau
3
,
Frank Grünhage
1
,
Jörn M Schattenberg
4
,
Heike Bantel
5
,
Anita Pathil
6
,
Münevver Demir
7
,
Johannes Kluwe
8
,
Tobias Boettler
9
,
Andreas Geier
3
,
Frank Lammert
1
;
NAFLD Clinical Study Group (NAFLD CSG)
Affiliations
1
Department of Medicine II Saarland University Medical Center, Saarland University, Homburg, Germany.
2
Laboratory of Metabolic Liver Diseases Department of General, Transplant, and Liver Surgery Medical University of Warsaw, Warsaw, Poland.
3
Division of Hepatology, Department of Medicine II University Hospital Würzburg, Würzburg, Germany.
4
I Department of Medicine, University Medical Center Mainz, Johannes Gutenberg University, Mainz, Germany.
5
Department of Gastroenterology, Hepatology, and Endocrinology, Hannover Medical School, Hannover, Germany.
6
Department of Internal Medicine IV Gastroenterology and Hepatology, University of Heidelberg, Heidelberg, Germany.
7
Clinic for Gastroenterology and Hepatology, University Hospital of Cologne, Cologne, Germany.
8
I Department of Medicine, Hamburg University Medical Center, Hamburg, Germany.
9
Department of Medicine II, Medical Center Faculty of Medicine, University of Freiburg, Freiburg, Germany.
PMID:
28176361
DOI:
10.1002/hep.29100
No abstract available
Publication types
Letter
Comment
MeSH terms
ATP Binding Cassette Transporter, Subfamily B
Cholestasis*
Humans
Liver Cirrhosis*
Substances
ATP Binding Cassette Transporter, Subfamily B